Affimed N.V.

(AFMD) Trade

By |

Profile

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's own immune defenses to fight tumor cells. It is also developing single and combination therapies to treat cancers and other life-threatening diseases. The company generates its pipeline of product candidates from several proprietary platform technologies NK-cell and T-cell TandAbs, tri specific Abs and alternative antibody formats.

Contact Information

Website: www.affimed.com
Email: ir@affimed.com
Main Phone: +49 6221653070
Address: Technologiepark
Address 2: Im Neuenheimer Feld 582
City / Town: Heidelberg
Country: DEU
Postal Code: 69120

Issuer Information

Exchange: NSD
CEO: Adi Hoess
Employees: 89
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 3.41 $ -0.32 (-8.58%)
Last Price 3.41 Change $ -0.32 Change % -8.58 Tick N/A
Bid 3.29 Bid Size 700.00 Ask 3.77 Ask Size 700.00
Open 3.70 High 3.73 Low 3.37 Prev Close 3.73
Last Trade Volume 1.2 mi 52 Wk Hi 7.35 52 Wk Low 1.15
Market Cap 212.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 62,427,920.00 EPS (TTM) -0.74 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 6.5 6.5 6.5 6.5
Standard Deviation 3.77 3.77 3.77 3.77
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 06/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.67